Resumo

TALAVERA, Gricelda, RODRIGUEZ, Magdalena, CASTRO, Héctor et al. Colonización intestinal por enterococo resistente a la vancomicina en pacientes  oncológicos con factores de riesgo. Pediatr. (Asunción), ago. 2011, vol.38, no.2, p.123-125. ISSN 1683-9803.

The study objectives were to determine the prevalence of intestinal colonization by vancomycin-resistant enterococci (VRE) in cancer patients with risk factors and describe their clinical and demographic characteristics. A longitudinal study conducted between December 1, 2008 and March 30, 2010, in patients aged ≤18 years. A total of 33 patients were included. VRE were isolated in 94% (31/33), of whom 39% (12/31) were age 10-14 years. 58% (18/31) were male, and 21/31 presented acute lymphoblastic leukemia (ALL). All had previously received antibiotics, 90% (28/31) vancomycin. 84% (26/31) had central venous catheters (CVC), 2/31 had surgery, and 1/31 MV. Contact precautions were implemented. In conclusion, a high rate of VRE colonization was observed. CVC and use of vancomycin were predominant. It is important to continue the established measures, monitoring, and the prudent use of vancomycin.

Palavras-chave: Vancomycin-resistant enterococci; intestinal colonization; cancer patients; pediatrics.